Search

Your search keyword '"Trivisano, M"' showing total 170 results

Search Constraints

Start Over You searched for: Author "Trivisano, M" Remove constraint Author: "Trivisano, M"
170 results on '"Trivisano, M"'

Search Results

1. Changing Times for CLN2 Disease: The Era of Enzyme Replacement Therapy

2. WWOX developmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk

3. Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome

4. Surgical management of pediatric intracranial CCM: a 10-year single center experience

5. Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome

6. Climate change and epilepsy: Insights from clinical and basic science studies

7. Reply to dravet, c. Different outcomes of acute encephalopathy after status epilepticus in patients with dravet syndrome. how to avoid them? comment on “de liso et al. fatal status epilepticus in dravet syndrome. brain sci. 2020, 10, 889”

8. Epilepsy and BRAF mutations: Phenotypes, natural history and genotype-phenotype correlations

10. A standardized patient-centered characterization of the phenotypic spectrum of PCDH19 girls clustering epilepsy

11. Defining the phenotype of FHF1 developmental and epileptic encephalopathy

12. Fatal status epilepticus in dravet syndrome

13. Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: A real-world study

17. Prognostic patterns and predictors in epilepsy: A multicentre study (PRO-LONG)

18. The Genetic Landscape of Epilepsy of Infancy with Migrating Focal Seizures.

19. The Genetic Landscape of Epilepsy of Infancy with Migrating Focal Seizures

20. Defining the electroclinical phenotype and outcome of PCDH19-related epilepsy: A multicenter study

21. Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features

22. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders

23. Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study

24. Clinical and genetic factors predicting Dravet syndrome in infants with SCN1A mutations

27. Progressive myoclonus epilepsy in Down syndrome patients with dementia

28. Spectrum of phenotypes in female patients with epilepsy due to protocadherin 19 mutations

30. 62. Video-polygraphic features of myoclonic epilepsy in down syndrome with Alzheimer’s disease

32. 2FC1.4 Epilepsy in girls with de novo protocadherin 19 mutations.

33. Childhood refractory focal epilepsy following acute febrile encephalopathy

36. A novel de novo SCN1A missense mutation in severe myoclonic epilepsy borderland

40. Advances in genetic testing and optimization of clinical management in children and adults with epilepsy

41. Surgical management of pediatric intracranial CCM: a 10-year single center experience

42. TELEmedicine for EPIlepsy Care (TELE-EPIC): Protocol of a randomised, open controlled non-inferiority clinical trial

43. A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion

44. Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study

45. Epilepsy in ring 14 chromosome syndrome

46. The expanding field of genetic developmental and epileptic encephalopathies: current understanding and future perspectives.

47. Unveiling the disease progression in developmental and epileptic encephalopathies: Insights from EEG and neuropsychology.

48. POLR3B de novo variants are a rare cause of infantile myoclonic epilepsy.

49. Clinical features and genotype-phenotype correlations in epilepsy patients with de novo DYNC1H1 variants.

50. Hypothalamic Hamartoma related epilepsy: A systematic review exploring clinical, neuropsychological, and psychiatric outcome after surgery.

Catalog

Books, media, physical & digital resources